A few days ago，The National Pharmaceutical Clinical Test Quality Management Conference co -sponsored by the Ministry of Health and the State Food and Drug Administration was held in Beijing，The National Bureau issued three specific measures to regulate the clinical trials of drugs。

1 is to implement classification management。According to the principle of risk management，Make a batch of good -conditioning drug clinical trial institutions standing out，Responsible for the heavy responsibility of innovative drug research，Leading clinical trial institutions based on exploratory research，Professional trial institution based on verified research、Netlated new pattern。In order to guide the team building and capacity building Stake Sports Bettingof stake sports betting appphase I clinical trials，The State Administration has formulated the "Principles of Phase I Clinical Test Management Guidance"，A corresponding inspection criteria will be formulated accordingly when appropriately。Future，Only confirmed clinical trials can conduct the first human test of innovative drugs。

The second is to establish a drug clinical trial supervision information system with informationization as a carrier，Lay the foundation for the dynamic supervision of the regulatory authorities and information sharing of relevant departments。

Third is to improve the method of on -site inspection。Combining varieties inspection with institutional inspection，Early (Qualification identification check)、In the event (process inspection)、After the after -after (project inspection) management stake online sports bettingMy stake betting appcombined，Work mode combined with technical review and on -site inspection，Give full play to the maximum efficacy of on -site inspection。For the problems of clinical trial institutions，The State Administration will increase the treatment，For a serious violation of GCP or even fake fake，No longer given rectification opportunities，Directly cancel the qualifications of clinical trial institutions and expose it。